Payment Breakdown by Category
Payments by Nature
| Nature of Payment | Amount | Transactions | Share |
|---|---|---|---|
| Food and Beverage | $172.36 | 3 | 84.2% |
| Education | $32.32 | 2 | 15.8% |
Top Paying Companies
| Company | Total | Records | Latest Year |
|---|---|---|---|
| Organogenesis Inc. | $141.25 | 2 | $0 (2023) |
| Galderma Laboratories, L.P. | $32.32 | 2 | $0 (2018) |
| Sientra, Inc. | $31.11 | 1 | $0 (2020) |
Payment History by Year
| Year | Amount | Transactions | Top Company |
|---|---|---|---|
| 2023 | $141.25 | 2 | Organogenesis Inc. ($141.25) |
| 2020 | $31.11 | 1 | Sientra, Inc. ($31.11) |
| 2018 | $32.32 | 2 | Galderma Laboratories, L.P. ($32.32) |
All Payment Transactions
5 individual payment records from CMS Open Payments
| Date | Company | Product | Nature | Form | Amount | Type |
|---|---|---|---|---|---|---|
| 04/18/2023 | Organogenesis Inc. | Puraply (Medical Supply) | Food and Beverage | Cash or cash equivalent | $60.81 | General |
| Category: Wound Care | ||||||
| 03/02/2023 | Organogenesis Inc. | Puraply (Medical Supply) | Food and Beverage | Cash or cash equivalent | $80.44 | General |
| Category: Wound Care | ||||||
| 09/14/2020 | Sientra, Inc. | SIENTRA HIGH STRENGTH COHESIVE SILICONE GEL BREAST IMPLANT (Device) | Food and Beverage | Cash or cash equivalent | $31.11 | General |
| Category: BREAST AUGMENTATION & RECONSTRUCTION | ||||||
| 10/08/2018 | Galderma Laboratories, L.P. | — | Education | In-kind items and services | $16.16 | General |
| 10/08/2018 | Galderma Laboratories, L.P. | — | Education | In-kind items and services | $16.16 | General |
Medicare Billing by Year
| Year | Procedures | Beneficiaries | Services | Submitted | Medicare Paid |
|---|---|---|---|---|---|
| 2023 | 7 | 264 | 811 | $61,606 | $20,809 |
| 2022 | 6 | 263 | 779 | $55,521 | $19,382 |
| 2021 | 6 | 292 | 705 | $53,317 | $18,971 |
| 2020 | 7 | 326 | 716 | $56,040 | $17,521 |
All Medicare Procedures & Services
26 procedure records from CMS Medicare Utilization — Page 1 of 2
| HCPCS | Description | Setting | Year | Patients | Services | Charges | Medicare Paid | Ratio |
|---|---|---|---|---|---|---|---|---|
| 99213 | Established patient office or other outpatient visit, 20-29 minutes | Office | 2023 | 76 | 128 | $19,300 | $7,563 | 39.2% |
| 11102 | Biopsy of related skin growth, first growth | Office | 2023 | 38 | 50 | $7,500 | $3,400 | 45.3% |
| 17000 | Destruction of precancer skin growth, 1 growth | Office | 2023 | 53 | 74 | $11,988 | $2,896 | 24.2% |
| 17003 | Destruction of precancer skin growth, 2-14 growths | Office | 2023 | 45 | 463 | $6,945 | $2,124 | 30.6% |
| 17004 | Destruction of precancer skin growth, 15 or more growths | Office | 2023 | 18 | 20 | $6,178 | $1,853 | 30.0% |
| 11103 | Biopsy of related skin growth, each additional growth | Office | 2023 | 15 | 48 | $7,200 | $1,806 | 25.1% |
| 99212 | Established patient office or other outpatient visit, 10-19 minutes | Office | 2023 | 19 | 28 | $2,495 | $1,166 | 46.7% |
| 99213 | Established patient office or other outpatient visit, 20-29 minutes | Office | 2022 | 74 | 128 | $19,300 | $8,178 | 42.4% |
| 17000 | Destruction of precancer skin growth, 1 growth | Office | 2022 | 66 | 104 | $16,848 | $4,179 | 24.8% |
| 11102 | Biopsy of related skin growth, first growth | Office | 2022 | 34 | 43 | $6,450 | $2,897 | 44.9% |
| 17003 | Destruction of precancer skin growth, 2-14 growths | Office | 2022 | 57 | 453 | $6,795 | $2,159 | 31.8% |
| 11103 | Biopsy of related skin growth, each additional growth | Office | 2022 | 12 | 26 | $3,900 | $1,016 | 26.0% |
| 99212 | Established patient office or other outpatient visit, 10-19 minutes | Office | 2022 | 20 | 25 | $2,228 | $954.14 | 42.8% |
| 99213 | Established patient outpatient visit, total time 20-29 minutes | Office | 2021 | 71 | 109 | $16,435 | $7,336 | 44.6% |
| 11102 | Tangential biopsy of single skin lesion | Office | 2021 | 48 | 56 | $8,400 | $3,951 | 47.0% |
| 17000 | Destruction of skin growth | Office | 2021 | 68 | 90 | $14,580 | $3,417 | 23.4% |
| 17003 | Destruction of 2-14 skin growths | Office | 2021 | 63 | 388 | $5,820 | $1,775 | 30.5% |
| 11103 | Tangential biopsy of additional skin lesion | Office | 2021 | 24 | 42 | $6,300 | $1,666 | 26.4% |
| 99212 | Established patient outpatient visit, total time 10-19 minutes | Office | 2021 | 18 | 20 | $1,782 | $826.50 | 46.4% |
| 99213 | Established patient office or other outpatient visit, typically 15 minutes | Office | 2020 | 71 | 86 | $12,967 | $4,661 | 35.9% |
| 11102 | Tangential biopsy of single skin lesion | Office | 2020 | 50 | 58 | $8,700 | $4,094 | 47.1% |
| 17000 | Destruction of skin growth | Office | 2020 | 72 | 83 | $13,446 | $2,551 | 19.0% |
| 17004 | Destruction of 15 or more skin growths | Office | 2020 | 17 | 19 | $5,869 | $1,991 | 33.9% |
| 11103 | Tangential biopsy of additional skin lesion | Office | 2020 | 22 | 39 | $5,850 | $1,598 | 27.3% |
| 17003 | Destruction of 2-14 skin growths | Office | 2020 | 64 | 394 | $5,910 | $1,545 | 26.1% |
About Dr. Keith Perrine, MD
Dr. Keith Perrine, MD is a Plastic Surgery healthcare provider based in Dayton, Ohio. This provider has been registered with the National Plan and Provider Enumeration System (NPPES) since 08/30/2006. The National Provider Identifier (NPI) number assigned to this provider is 1720198112.
According to the Centers for Medicare & Medicaid Services (CMS) Open Payments database, Dr. Keith Perrine, MD has received a total of $204.68 in payments from pharmaceutical and medical device companies, with $141.25 received in 2023. These payments were reported across 5 transactions from 3 companies. The most common payment nature is "Food and Beverage" ($172.36).
As a Medicare-enrolled provider, Perrine has provided services to 1,145 Medicare beneficiaries, totaling 3,011 services with total Medicare billing of $76,683. Data is available for 4 years (2020–2023), covering 26 distinct procedure/service records.
Practice Information
- Specialty Plastic Surgery
- Other Specialties Plastic Surgery
- Location Dayton, OH
- Active Since 08/30/2006
- Last Updated 10/01/2012
- Taxonomy Code 208200000X
- Entity Type Individual
- Practice Solo Practitioner
- NPI Number 1720198112
Products in Payments
- Puraply (Medical Supply) $141.25
- SIENTRA HIGH STRENGTH COHESIVE SILICONE GEL BREAST IMPLANT (Device) $31.11
Data Sources
Provider data from NPPES. Payment data from CMS Open Payments. Medicare data from CMS Medicare Provider Utilization. All data is public and updated periodically.